These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35500592)

  • 1. A call for loiasis to be added to the WHO list of neglected tropical diseases.
    Jacobsen KH; Andress BC; Bhagwat EA; Bryant CA; Chandrapu VR; Desmonts CG; Matthews TM; Ogunkoya A; Wheeler TJ; Williams AS
    Lancet Infect Dis; 2022 Oct; 22(10):e299-e302. PubMed ID: 35500592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
    Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
    Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.
    Kelly-Hope LA; Hemingway J; Taylor MJ; Molyneux DH
    Parasit Vectors; 2018 Jun; 11(1):349. PubMed ID: 29907117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess mortality associated with loiasis: a retrospective population-based cohort study.
    Chesnais CB; Takougang I; Paguélé M; Pion SD; Boussinesq M
    Lancet Infect Dis; 2017 Jan; 17(1):108-116. PubMed ID: 27777031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
    Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
    Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
    Sumo L; Ntonifor NH; Afor AR; Bopda J; Bamou Heumou R; Ondoua Nganjou GS; Nana Djeunga HC
    Acta Trop; 2022 Jan; 225():106218. PubMed ID: 34755644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
    Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
    Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
    Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
    Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
    Johnson O; Giorgi E; Fronterrè C; Amoah B; Atsame J; Ella SN; Biamonte M; Ogoussan K; Hundley L; Gass K; Diggle PJ
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010189. PubMed ID: 35139080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a
    Brito M; Paulo R; Van-Dunem P; Martins A; Unnasch TR; Novak RJ; Jacob B; Stanton MC; Molyneux DH; Kelly-Hope LA
    Parasite Epidemiol Control; 2017 Aug; 2(3):71-84. PubMed ID: 29774284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
    Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
    Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
    Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
    Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental factors associated with the distribution of Loa loa vectors Chrysops spp. in Central and West Africa: seeing the forest for the trees.
    Badia-Rius X; Betts H; Molyneux DH; Kelly-Hope LA
    Parasit Vectors; 2019 Feb; 12(1):72. PubMed ID: 30728063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.